Global Cancer Imaging Systems Market - Analysis and Forecast (2017-2025)

Focus on Products (Analog Mammography, Digital Breast Tomosynthesis, Molecular Breast Imaging, MRI, CT, PET, and others), Cancer Types, End Users, 26 Country Analysis, Patent Analysis, Market Share Analysis, Growth Share Matrix, and Competitive Landscape

Published Year: 2017
SKU: BHP0512SA
View TOC Request Sample

4599

Online Access for 1-3 Users. Permission to Print.


In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

A quick peek into the report

Report Description

The cancer imaging systems market is growing at an exponential rate with the increasing incidence of various types of cancer and a

Read More

Key Questions Answered in this Report

What are the major market drivers, challenges and opportunities of the global cancer imaging systems market?

Read More

Market Overview

The cancer imaging systems market is growing at an exponential rate with the increasing incidence of various types of cancer and a

Read More

Table of Contents

Request a Sample

Report Scope and Methodology

1.1. Scope of the Report
1.2. Global Cancer Imaging Systems Market Segmentation
1.3 Key Learnings
1.4 Research Methodology
1.4.1. Data Triangulation
1.4.2. Key Data Points from Secondary Sources
1.4.3. Secondary Data Sources 
1.4.4. Key Data Points From Primary Sources 
1.4.5. Top-Down  Approach (Segmental Analysis)
1.4.6. Bottom-Up Approach (Segmental Analysis)
1.4.7. Assumptions and Limitations
1.4.8 Data and Prediction Modelling

Market Overview

2.1 Overview
2.2 Important Facts 
2.3 Estimated Number of New Cases of Cancer and Deaths by Gender, U.S., 2017
2.4 Discovery of Medical Imaging Modalities  
2.5 Developments in imaging modalities 
2.6 Role of Imaging in Oncology Decision Process
2.7 Radiation Risk
2.8 Potential Benefits & Risks of Medical Imaging 
2.9 Recent Developments 

Market Dynamics

3.1 Overview
3.2 Market Drivers
3.3. Market Challenges
3.4 Market Opportunities

Competitive Landscape

4.1. Key Development and Strategies
4.1.1 New Product Launches and Developments
4.1.2 Patents, Approvals and Certifications 
4.1.3 Business Expansions/Contracts 
4.1.4 Collaborations, Joint Ventures and Partnerships
4.1.5 Others
4.2. Emerging Trends in Medical Imaging Technology 
4.3 Legal Requirements and Regulations
4.4 Market Share Analysis 
4.5 Analysis 
4.6 Growth Share Matrix
4.7 Analysis 

Industry Analysis

5.1 Patent Landscape
5.2.  Consortiums, Associations, and Regulatory Bodies
5.3 Analysis- Assumption & Limitations 

Global Cancer Imaging Systems Market, by Product

6.1.  Overview
6.2 Mammography 
6.2.1 Analog Mammography 
6.2.2 Full Field Digital Mammography 
6.2.3 Digital Breast Tomosynthesis (DBT)
6.2.4 Some of the Key Market Players  
6.3 Computed Tomography 
6.4 Molecular Breast Imaging (MBI)
6.5 Magnetic Resonance Imaging (MRI)
6.6 Positron Emission Tomography (PET)
6.7 Ultrasound
6.8 Others 

Global Cancer Imaging Systems Market, by Cancer Types

7.1 Overview
7.2 Breast Cancer 
7.3 Lung Cancer 
7.4 Prostate Cancer
7.5 Colorectal Cancer
7.6 Liver Cancer 
7.7 Other Cancers 

Global Cancer Imaging Systems Market, by End-User

8.1 Overview
8.2 Hospitals 
8.3 End-User
8.4 Others

Global Cancer Imaging Systems Market, by Region

9.1 Overview
9.2 North America 
9.2.1 North America by Country Analysis 
9.2.2 The U.S.
9.2.3 Canada 
9.3 Europe
9.3.1 Europe by Country Analysis 
9.3.2 Germany
9.3.3 France
9.3.4 The U.K.
9.3.5 Italy
9.3.6 Spain
9.3.7 Netherlands
9.3.8 Belgium
9.3.9 Rest of Europe
9.4 Asia-Pacific 
9.4.1 Asia-Pacific by Country Analysis 
9.4.2 Japan
9.4.3 China
9.4.4 Australia 
9.4.5 South Korea 
9.4.6 India
9.4.7 Malaysia 
9.4.8 Indonesia 
9.4.9 Rest of Asia-Pacific 
9.5 Latin America 
9.5.1 Latin America by Country Analysis 
9.5.2 Brazil
9.5.3 Mexico
9.5.4 Rest of Latin America 
9.6 Rest of World (RoW)
9.6.1 Rest of the World by Country Analysis 
9.6.2 Russia 
9.6.3 Saudi Arabia 
9.6.4 Israel
9.6.5 South Africa 
9.6.6 United Arab Emirates (UAE)
9.6.7 Rest of RoW

Company Profiles

10.1 Carestream Health
10.1.1 Overview
10.1.2 Product Mapping 
10.1.3 Overall Summary
10.1.4 SWOT Analysis 
10.2 Dilon Diagnostics 
10.2.1 Overview
10.2.2 Product Mapping
10.2.3 Overall Summary
10.2.4 SWOT Analysis 
10.3 Esaote
10.3.1 Overview
10.3.2 Product Mapping
10.3.3 Overall Summary
10.3.4 SWOT Analysis 
10.4 Fujifilm Holdings Corporation 
10.4.1 Overview
10.4.2 Product Mapping
10.4.3 Financials 
10.4.3.1 Financial Summary 
10.4.4 SWOT Analysis 
10.5 Gamma Medica Inc. 
10.5.1 Overview
10.5.2 Product Mapping 
10.5.3 Overall Summary 
10.5.4  SWOT Analysis 
10.6 GE Healthcare 
10.6.1 Overview: GE Healthcare 
10.6.2 Overview: General Electric
10.6.3 Product Mapping
10.6.4 Financials 
10.6.4.1 Finacial Summary
10.6.5 SWOT Analysis 
10.7 Hitachi Medical Corporation
10.7.1 Overview: Hitachi Medical Corporation
10.7.2 Overview: Hitachi
10.7.3 Financials 
10.7.3.1 Finacial Summary
10.7.4 SWOT Analysis 
10.8 Hologic Inc.
10.8.1 Overview
10.8.2 Product Mapping
10.8.3 Financials
10.8.3.1 Financial Summary 
10.8.4 SWOT Analysis 
10.9 Konica Minolta
10.9.1 Overview
10.9.2 Product Mapping
10.9.3 Financials
10.9.3.1 Financial Summary 
10.9.4 SWOT Analysis 
10.10 Neusoft Medical
10.10.1 Overview: Neusoft Medical
10.10.2 Overview: Neusoft Corporation
10.10.3 Product Mapping
10.10.4 Financials 
10.10.4.1 Financial Summary 
10.10.5 SWOT Analysis 
10.11 Philips Group 
10.11.1 Overview
10.11.2 Product Mapping
10.11.3 Financials 
10.11.3.1 Financial Summary 
10.11.4 SWOT Analysis 
10.12 Samsung Medison Co. Ltd.
10.12.1 Overview: Samsung Medison Co. Ltd.
10.12.2 Overview: Samsung Electronics Co. Ltd.
10.12.3 Product Mapping
10.12.4 Financials 
10.12.4.1 Financial Summary 
10.12.5 SWOT Analysis 
10.13 Shimadzu Corporation
10.13.1 Overview
10.13.2 Product Mapping
10.13.3 Financials 
10.13.3.1 Financial Summary 
10.13.4 SWOT Analysis 
10.14 Siemens Healthineers 
10.14.1 Overview: Siemens Healthineers 
10.14.2 Overview: Siemens 
10.14.3 Product Mapping
10.14.4 Financials
10.14.4.1 Financial Summary
10.14.5 SWOT Analysis 
10.15 Toshiba Medical Corporation
10.15.1 Overview: Toshiba Medical Corporation
10.15.2 Overview: Canon Inc.
10.15.3 Product Mapping
10.15.4 Financials
10.15.4.1 Financial Summary
10.15.5 SWOT Analysis 
10.16 Analogic Corporation
10.16.1 Overview
10.17 Aurora Imaging Technology, Inc.
10.17.1  Overview
10.18 Bruker Corporation
10.18.1 Overview
10.19 Koning Corporation
10.19.1 Overview
10.20 MR Solutions 
10.20.1 Overview
10.21 NCD Company 
10.21.1 Overview
10.22 Perkin Elmer 
10.22.1 Overview
10.23 Planmed Oy
10.23.1 Overview
10.24 Spectrum Medical Imaging 
10.24.1 Overview
10.25 UMG/DEL Medical Imaging 
10.25.1 Overview
10.26 Varian Medical Systems 
10.26.1 Overview

List of Tables

1 Difference Between Screening Test and Diagnostic Test 
2 Cancer Types Patient Data 
3 Imaging Procedures & Their Approximate Effective Radiation Doses 
4 New Product Launches and Developments 
5 Patents, Approvals and Certifications 
6 Business Expansions/Contracts 
7 Collaborations, Joint Ventures & Partnerships
8 Other Strategies
9 Patent Landscape
10 Consortiums, Associations and Regulatory Bodies
11 Global Cancer Imaging Systems Market by Product, 2016-2025 ($Million)
12 Mammogram Screening Reported, 2014-2015
13 APAC Mammogram Units Reported, 2014
14 CT Scan Volume Data, 2015  
15 MRI (Some of the National Average Billings)
16 MRI Scan Volume data, 2015
17 Breast Cancer Patient Data in Top Countries, (2014-2021)
18 The U.S. Breast Screening Data 
19 Lung Cancer Patient Data in Top Countries, (2014-2021)
20 Summary of prostate cancer imaging modalities   
21 Prostate Cancer Patient Data in Top Countries, (2014-2021)
22 Colorectal Cancer Patient Data  in Top Countries, (2014-2021)
23 Liver Cancer Patient Data in Top Countries, (2014-2021)
24 Stomach Cancer Patient Data in Top Countries, (2014-2021) 
25 Total Number of Hospitals   
26 Total Number of U.S. Outpatient Diagnostic Imaging Centres   
27 CT installation in ambulatory care services
28 MRI installation in ambulatory care services
29 European Key Market Players 
30 Installed Modalities in India, 2015 
31 Overview: Carestream Health
32 Overview: Dilon Diagnostics 
33 Overview: Esaote
34 Overview: Fujifilm Holdings Corporation 
35 Overview: Gamma Medica Inc.
36 Overview: GE Healthcare 
37 Overvie: General Electric 
38 Overview:  Hitachi Medical Corporation
39 Overview: Hitachi
40 Overview: Holgic Inc.
41 Overview: Konica Minolta 
42 Overview:  Neusoft Medical 
43 Overview: Neusoft Corporation
44 Overview: Philips Group
45 Overview: Samsung Medison Co. Ltd.
46 Overview:  Samsung Electronics Co. Ltd.
47 Overview: Shimadzu Corporation
48 Overview: Siemens Healthineers 
49 Overview: Siemens
50 Overview: Toshiba Medical Corporation
51 Overview: Canon Inc.
52 Overview: Analogic Corporation
53 Overview: Aurora Imaging Technology, Inc.
54 Overview: Bruker Corporation 
55 Overview: Koning Corporation 
56 Overview: MR Solutions 
57 Overview: NCD Company
58 Overview: Perkin Elmer
59 Overview: Planmed Oy
60 Overview: Spectrum Medical Imaging 
61 UMG/DEL Medical Imaging
62 Varian Medical Systems 

List of Figures

1 Cancer Imaging Systems  Drivers & Challenges 
2 Cancer Imaging Systems Market Share by Product, 2016
3 Cancer Imaging Systems Market Share by Product, 2025
4 Global Cancer Imaging Systems Market by Product Growth Rate (2017-2025)
5 Cancer Imaging Systems Market Share by Application, 2016
6 Cancer Imaging Systems Market Share by Application, 2025
7 Global Cancer Imaging Systems Market by Application Growth Rate (2017-2025)
8 Cancer Imaging Systems Market Share by End-User, 2016
9 Cancer Imaging Systems Market Share by End-User, 2025
10 Global Cancer Imaging Systems Market by End-User Growth Rate (2017-2025)
11 Global Cancer Imaging Systems Market Share by Region, 2016
12 Global Cancer Imaging Systems Market Share by Region, 2025
13 Global Cancer Imaging Systems Market by Geographical Growth Rate (2017-2025)
14 Global Cancer Imaging Systems Market by Countries Growth Rate (2017-2025)
15 Global Cancer Imaging Systems Market Value by Region, 2016 & 2025 ($Million
16 Global Cancer Imaging Systems Market Segmentation
17 Research Methodology
18 Data Traingulation
19 Key Data Points From Secondary Sources 
20 Secondary Data Sources
21 Key Data Points From Primary Sources 
22 Top-Down  Approach (Segmental Analysis)
23 Bottom-Up Approach (Segmental Analysis)
24 Assumptions and Limitations
25 Data and Prediction Modelling
26 Important Facts 
27 Estimated Number of New Cases of Cancer and Deaths by Gender, U.S., 2017
28 Discovery of Medical Imaging Modalities  
29 Potential Benefits & Risks of Medical Imaging    
30 Market Dynamics
31 Market Drivers
32 Market Challenges
33 Market Opportunities
34 Recent Market Development Strategy Snapshot Analysis
35 Key Market Developments & Strategies
36 Emerging Trends in Medical Imaging Technology 
37 Diagnostic Imaging Market Share by Company, 2015
38 Diagnostic Imaging Market Share by Company, 2016
39 Growth Share Matrix
40 Global Cancer Imaging Systems Market by Product 
41 Analog Mammography Cancer Imaging Systems Market, 2016-2025 ($Million)
42 Global Cancer Imaging Analog Mammography Market by Region, 2016-2025 ($Million)
43 Full Field Digital Mammography Cancer Imaging Systems Market, 2016-2025 ($Million)
44 Global Cancer Imaging Full Field Digital Mammography  Market by Region, 2016-2025 ($Million)
45 Digital Breast Tomosynthesis Cancer Imaging Systems Market, 2016-2025 ($Million)
46 Global Cancer Imaging Digital Breast Tomosynthesis  Market by Region, 2016-2025 ($Million)
47 Pros & Cons of Conventional Mammography Technique
48 Pros & Cons of Digital Mammography
49 Tumor Size Indicators 
50 Palpable Nodes Indicators 
51 Metastasis Indicators 
52 Mammography Units per Million Population (OECD countries) 2015
53 Computed Tomography Cancer Imaging Systems Market, 2016-2025 ($Million)
54 Global Cancer Imaging Computed Tomography Market by Region, 2016-2025 ($Million)
55 Use of CT in cancer imaging 
56 CT Units per Million Population (OECD countries) 2015
57 Molecular Breast Imaging Cancer Imaging Systems Market, 2016-2025 ($Million)
58 Global Cancer Imaging Molecular Breast Imaging Market by Geography, 2016-2025 ($Million)
59 Breast Density 
60 Causes for Growth of  Dense Breast Tissues 
61 Certain Pros & Cons of Molecular Breast Imaging (MBI)  
62 Magnetic Resonance Imaging Cancer Imaging Systems Market, 2016-2025 ($Million)
63 Global Cancer Imaging Magnetic Resonance Imaging Market by Geography, 2016-2025 ($Million)
64 Types of MRI
65 MRI Units Per Million Population (OECD countries 2015)
66 Positron Emission Tomography Cancer Imaging Systems Market, 2016-2025 ($Million)
67 Global Cancer Imaging Positron Emission Tomography Market by Geography, 2016-2025 ($Million)
68 Uses of PET Scan 
69 Some of the Tracers Used in PET
70 Application Area of PET (%)
71 PET Scanner 
72 PET Scan Image  
73 Pros & Cons of PET 
74 Ultrasound Cancer Imaging Systems Market, 2016-2025 ($Million)
75 Global Cancer Imaging Ultrasound Market by Geography, 2016-2025 ($Million)
76 Common Ultrasound Imaging Procedures 
77 Advantages & Disadvantages of Ultrasound 
78 Other Products in the Cancer Imaging Systems Market, 2016-2025 ($Million)
79 Global Cancer Imaging Other Products Market by Geography, 2016-2025 ($Million)
80 Global Cancer Imaging Market by Cancer Types
81 Global Cancer Imaging Systems Market by Application, 2016-2025 ($Million) 
82 Breast Cancer Application Cancer Imaging Systems Market, 2016-2025 ($Million)
83 Percentage of New Breast Cancer Cases by Age Group (2010-2014)
84 Breast Cancer Patient Data (2016)
85 Imaging Modalities Used for Breast Cancer 
86 Lung Cancer Application Cancer Imaging Systems Market, 2016-2025 ($Million)
87 Stages of Non-Small Cell Lung Cancer  
88 Imaging Modalities Used for Lung Cancer 
89 Prostate Cancer Application Cancer Imaging Systems Market, 2016-2025 ($Million)
90 Prostate Cancer Patient Data (2016)
91 Colorectal Cancer Application Cancer Imaging Systems Market, 2016-2025 ($Million)
92 Imaging Modalities Used for Colorectal Cancer 
93 Colorectal cancer by Age
94 Colorectal Cancer Patient Data (2016)
95 Liver Cancer Application Cancer Imaging Systems Market, 2016-2025 ($Million)
96 Liver Cancer Patient Data (2016)
97 Imaging Modalities Used for Liver Cancer 
98 Other Cancers Application Cancer Imaging Systems Market, 2016-2025 ($Million)
99 Cancer imaging Systems Market by End-User  
100 Global Cancer Imaging Systems Market by End-Users, 2016-2025 ($Million) 
101 Hospitals Cancer Imaging Systems Market, 2016-2025 ($Million)
102 Global Cancer Imaging Hospitals Market by Application, 2016-2025 ($Million)
103 Diagnostic Imaging Centers Cancer Imaging Systems Market, 2016-2025 ($Million)
104 Global Cancer Imaging Diagnostic Imaging Centers Market by Application, 2016-2025 ($Million)
105 Other End-User Cancer Imaging Systems Market, 2016-2025 ($Million)
106 Global Cancer Imaging Others Market by Application, 2016-2025 ($Million)
107 Global Scenario 
108 Global Cancer Imaging Systems Market by Region, 2016-2025 ($Million)
109 North America Cancer Imaging Systems Market, 2016-2025 ($Million)
110 North America Cancer Imaging Systems Market by Country, 2016-2025 ($Million)
111 U.S. Cancer Imaging System Market, 2016-2025 ($Million)
112 Canada Cancer Imaging System Market, 2016-2025 ($Million)
113 Cancer Patient Data by Cancers Type in the U.S. (2016
114 Cancer Patient Data by Cancers Type in Canada (2016)
115 Europe Cancer Imaging Systems Market, 2016-2025 ($Million)
116 Europe Cancer Imaging Systems Market by Country, 2016-2025($Million)
117 Germany Cancer Imaging System Market, 2016-2025 ($Million)
118 France Cancer Imaging System Market, 2016-2025 ($Million)
119 U.K. Cancer Imaging System Market, 2016-2025 ($Million)
120 Italy Cancer Imaging System Market, 2016-2025 ($Million)
121 Spain Cancer Imaging System Market, 2016-2025 ($Million)
122 Netherlands Cancer Imaging System Market, 2016-2025 ($Million)
123 Belgium Cancer Imaging System Market, 2016-2025 ($Million)
124 Rest of Europe Cancer Imaging System Market, 2016-2025 ($Million)
125 Key Market Drivers in the European Countries 
126 Denmark-Cancer Patient Data  
127 Germany-Cancer Patient Data (2016
128 France-Cancer Patient Data (2016)
129 Italy- Cancer Patient Data (2016)
130 Market Dynamics (Europe)
131 Asia-Pacific Cancer Imaging Systems Market , 2016-2025 ($Million)
132 Asia-Pacific Cancer Imaging Systems Market by Country, 2016-2025($Million)
133 Japan Cancer Imaging System Market, 2016-2025 ($Million)
134 China Cancer Imaging System Market, 2016-2025 ($Million)
135 Australia Cancer Imaging System Market, 2016-2025 ($Million)
136 South Korea Cancer Imaging System Market, 2016-2025 ($Million)
137 India Cancer Imaging System Market, 2016-2025 ($Million)
138 Malaysia Cancer Imaging System Market, 2016-2025 ($Million)
139 Japan Cancer Patient Data, 2016
140 China-Cancer Patient Data, 2016
141 Installed Modalities in India, 2015 
142 India-Cancer Patient Data,2016
143 Latin America Cancer Imaging Systems Market , 2016-2025 ($Million)
144 Latin America Cancer Imaging Systems Market by Country, 2016-2025($Million)
145 Brazil Cancer Imaging System Market, 2016-2025 ($Million)
146 Mexico Cancer Imaging System Market, 2016-2025 ($Million)
147 Rest of Latin America Cancer Imaging System Market, 2016-2025 ($Million)
148 Rest of World Cancer Imaging Systems Market , 2016-2025 ($Million)
149 RoW Cancer Imaging Systems Market by Country, 2016-2025($Million)
150 Russia Cancer Imaging System Market, 2016-2025 ($Million)
151 Saudi Arabia Cancer Imaging System Market, 2016-2025 ($Million)
152 Israel Cancer Imaging System Market, 2016-2025 ($Million)
153 South Africa Cancer Imaging System Market, 2016-2025 ($Million)
154 United Arab Emirates (UAE) Cancer Imaging System Market, 2016-2025 ($Million)
155 Rest of RoW Cancer Imaging System Market, 2016-2025 ($Million)
156 Qatar Cancer Patient Data,2016
157 Israel-Cancer Patient Data,2016
158 Egypt-Cancer Patient Data,2016
159 Saudi Arabia- Cancer Patient Data ,2016
160 Carestream Health: Product Mapping
161 Carestream Health: SWOT Analysis 
162 Dilon Diagnostics: Product Mapping
163 Dilon Diagnostics: SWOT Analysis 
164 Esaote: Product Mapping
165 Esaote: SWOT Analysis 
166 Fujifilm Holdings Corporation: Product Mapping
167 Fujifilm Holdings Corporation: Overall Financials (2014-2016)
168 Fujifilm Holdings Corporation: Net Revenue by Business Segment (2014-2016)
169 Fujifilm Holdings Corporation: Net Revenue by Business Sub-segment (2016)
170 Fujifilm Holdings Corporation: Net Revenue by Region (2014-2016)
171 Fujifilm Holdings Corporation: SWOT Analysis
172 Gamma Medica Inc.: Product Mapping
173 Gamma Medica Inc.: SWOT Analysis
174 General Electric: Product Mapping
175 General Electric: Overall Financials (2014-2016)
176 General Electric: Net Revenue by Business Segment (2014-2016)
177 General Electric: Net Revenue by Business Sub-Segment (2016)
178 General Electric: Net Revenue by Region (2014-2016)
179 General Electric: SWOT Analysis
180 Hitachi: Product Mapping
181 Hitachi: Overall Financials (2014-2016)
182 Hitachi: Net Revenue by Region (2014-2016)
183 Hitachi: Net Revenue by Business Segment (2014)
184 Hitachi: Net Revenue by Business Segment (2015-2016)
185 Hitachi: SWOT Analysis
186 Hologic Inc.: Product Mapping
187 Hologic Inc.: Overall Financials (2014-2016)
188 Hologic Inc.: Net Revenue by Business Segment (2014-2016)
189 Hologic Inc.: Net Revenue by Region (2014-2016)
190 Hologic Inc.: SWOT Analysis
191 Konica Minolta: Product Mapping 
192 Konica Minolta: Overall Financials (2014-2016)
193 Konica Minolta: Net Revenue by Business Segment (2014-2016)
194 Konica Minolta: Net Revenue by Geography  (2014-2016)
195 Konica Minolta: Net Revenue by Geography  (2014-2016)
196 Neusoft Corporation: Product Mapping
197 Neusoft Corporation: Overall Financials  (2014-2016)
198 Neusoft Corporation: SWOT Analysis 
199 Philips Group: Product Mapping
200 Philips Group: Overall Financial Performance (2014-2016)
201 Philips Group: Net Revenue by Business Segment (2015-2016)
202 Philips Group: Net Revenue by Geography (2014-2016)
203 Philips Group: Net Revenue by Business segment (2014)
204 Philips Group: Diagnostics & Treatment Sub-Segment% (2016)
205 Philips Group: SWOT Analysis
206 Samsung: Product Mapping
207 Samsung: Overall Financials (2014-2016)
208 Samsung: Net Revenue by Business Segment (2014-2016)
209 Samsung: Net Revenue by Region (2014-2016)
210 Samsung: SWOT Analysis 
211 Shimadzu Corporation: Product Mapping
212 Shimadzu Corporation: Overall Financials (2014-2016)
213 Shimadzu Corporation: Net Revenue by Business Segment (2014-2016)
214 Shimadzu Corporation: Net Revenue by Geography (2014-2016)
215 Shimadzu Corporation: SWOT Analysis
216 Siemens Healthineers: Product Mapping
217 Siemens Healthineers: Overall Financials (2014-2016)
218 Siemens Healthineers: Net Revenue by Region (2014-2016)
219 Siemens Healthineers: Net Revenue by Business Segment (2014-2016)
220 Siemens Healthineers: SWOT Analysis
221 Canon Inc. (Toshiba Medical Corporation): Product Mapping
222 Canon Inc. (Toshiba Medical Corporation): Overall Financials (2014-2016)
223 Canon Inc. (Toshiba Medical Corporation): Net Revenue by Business Segment (2014-2016)
224 Canon Inc. (Toshiba Medical Corporation): Net Revenue by Region  (2014-2016)
225 Canon Inc. (Toshiba Medical Corporation): SWOT Analysis

Global Cancer Imaging Systems Market - Analysis and Forecast (2017-2025)

Focus on Products (Analog Mammography, Digital Breast Tomosynthesis, Molecular Breast Imaging, MRI, CT, PET, and others), Cancer Types, End Users, 26 Country Analysis, Patent Analysis, Market Share Analysis, Growth Share Matrix, and Competitive Landscape

Contact Us

Request a Sample Schedule a Call